Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	227-229
Journal	Journal of thrombosis and haemostasis
Volume	6
Issue number	2
DOIs	https://doi.org/10.1111/j.1538-7836.2007.02848.x
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{b59fbe9bdfed42459f791dbbdb291091,

title = "Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants",

author = "B{\"u}ller, \{H. R.\} and Halperin, \{J. L.\} and H. Bounameaux and Prins, \{M. [=Martin H.]\}",

year = "2008",

doi = "10.1111/j.1538-7836.2007.02848.x",

language = "English",

volume = "6",

pages = "227--229",

journal = "Journal of thrombosis and haemostasis",

issn = "1538-7933",

publisher = "Wiley Blackwell",

number = "2",

}

TY - JOUR

T1 - Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants

AU - Büller, H. R.

AU - Halperin, J. L.

AU - Bounameaux, H.

AU - Prins, M. [=Martin H.]

PY - 2008

Y1 - 2008

U2 - 10.1111/j.1538-7836.2007.02848.x

DO - 10.1111/j.1538-7836.2007.02848.x

M3 - Editorial

C2 - 18034770

SN - 1538-7933

VL - 6

SP - 227

EP - 229

JO - Journal of thrombosis and haemostasis

JF - Journal of thrombosis and haemostasis

IS - 2

ER -